IonQ shares plunged 7.7% on heavy volume after reports suggested a postponement of its AQ-64 Tempo commercial system, originally slated for 2025. The sell-off saw the stock breach its 50-day and 200-day moving averages in a single session, triggering technical stop-loss orders and signaling growing investor unease about delivery timelines and revenue ramp expectations.

In its latest quarter, IonQ exceeded consensus revenue forecasts and raised full-year revenue guidance to as much as $110 million. This performance was driven by expanded software subscription bookings and new sales of cloud-based quantum compute hours. Despite these gains, revenue remains modest compared with capital-intensive R&D and infrastructure spend.

Through the first nine months of the year, IonQ incurred operating expenses of $473 million, more than four times its quarterly revenue run rate. To fund development of next-generation hardware and scale data center deployments, the company completed a $2 billion equity offering. While this infusion strengthens the balance sheet, it diluted existing shareholders by approximately 12%, raising concerns over long-term earnings per share dilution.